These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5711605)

  • 1. Mechanism of action of adrenergic beta-receptor blocking agents in the prevention of cyclopropane adrenaline-evoked ventricular arrhythmias in the dog.
    Sharma PL; Narang RS
    Indian J Med Res; 1968 Aug; 56(8):1256-64. PubMed ID: 5711605
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of cyclopropane-adrenaline-evoked ventricular arrhythmias in the dog by selective beta-receptor antagonists.
    Sharma PL
    Indian J Med Res; 1970 Jun; 58(6):731-9. PubMed ID: 4395006
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiarrhythmic activity of the dextro- and levorotatory isomers of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999).
    Somani P; Watson DL
    J Pharmacol Exp Ther; 1968 Dec; 164(2):317-25. PubMed ID: 5699093
    [No Abstract]   [Full Text] [Related]  

  • 4. Action of beta-adrenolytics on the isolated guinea-pig atria.
    Grodzińska L; Gryglewski R
    Arch Int Pharmacodyn Ther; 1971 May; 191(1):133-41. PubMed ID: 4397624
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of ventricular fibrillation thresholds after sympatholytic drugs in the dog.
    Wellens D; Wauters E
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):355-71. PubMed ID: 4403391
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cardiovascular effects of alprenolol(beta-blockade) under halothane anesthesia].
    Yoshida T; Kubota M; Tamura A; Suzuki K; Furukawa Y
    Masui; 1969 Nov; 18(11):1071-8. PubMed ID: 4391283
    [No Abstract]   [Full Text] [Related]  

  • 7. [Beta-receptor-blocking agents and their current clinical significance].
    Deptalla H; Wiegershausen B
    Dtsch Gesundheitsw; 1968 Dec; 23(50):2353-63. PubMed ID: 4389656
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-fibrillary and anti-adrenaline activity of beta-receptor blocking drugs.
    Raper C; Jowett A
    Eur J Pharmacol; 1967 Sep; 1(5):353-62. PubMed ID: 4385120
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacological actions of butidrine. A comparative study of this new beta-adrenergic receptor antagonist and its four stereoisomers.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1968 Jul; 18(7):829-33. PubMed ID: 4387812
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-arrhythmic ancd local anaesthetic activity of some beta-receptor blocking compounds.
    Hermansen K
    Br J Pharmacol; 1968 Sep; 34(1):200P. PubMed ID: 4300140
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46].
    Yoshida T; Takano M; Tamura A; Kubota H; Suzuki N
    Masui; 1970 May; 19(5):515-22. PubMed ID: 4393894
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective adrenergic beta-receptor blockade in the prevention of adrenaline-evoked ventricular arrhythmias in dogs anaesthetized with halothane in oxygen.
    Sharma PL
    Br J Anaesth; 1969 Jun; 41(6):481-8. PubMed ID: 5792880
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the local anaesthetic-, "quinidine-like"- and adrenergic beta-blocking-activities of five beta-receptor antagonists.
    Davis WG
    J Pharm Pharmacol; 1970 Apr; 22(4):284-90. PubMed ID: 4392570
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of propranolol and its optical isomers on the radiocalcium uptake and the adenosine triphosphatases of skeletal and cardiac sarcoplasmic reticulum fractions (SRF).
    Scales B; McIntosh DA
    J Pharmacol Exp Ther; 1968 Apr; 160(2):261-7. PubMed ID: 4384785
    [No Abstract]   [Full Text] [Related]  

  • 16. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of the adrenergic beta-receptors for thermogenesis and survival of acutely cold-exposed mice.
    Estler CJ; Ammon HP
    Can J Physiol Pharmacol; 1969 May; 47(5):427-34. PubMed ID: 5787302
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the mechanogram and other circulatory parameters induced by isoprenaline and adrenaline under the effect of verapamil, quinidine and adrenergic substances].
    Haas H
    Arzneimittelforschung; 1970 Apr; 20(4):501-9. PubMed ID: 5467814
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of six adrenergic beta receptor blockaders on auriculo-ventricular conduction in the dog].
    Giudicelli JF; Boissier JR
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):287-92. PubMed ID: 4402114
    [No Abstract]   [Full Text] [Related]  

  • 20. Antagonism of cardiac arrhythmias by dl-1-(2-acetyl-4-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane (M & B 17,803A), a new beta adrenoreceptor blocking agent.
    Laddu AR
    Jpn Heart J; 1974 Jan; 15(1):61-71. PubMed ID: 4151909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.